# Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

> **NCT04399824** · NA · WITHDRAWN · sponsor: **Jonsson Comprehensive Cancer Center**

## Conditions studied

- Prostate Adenocarcinoma
- Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
- Stage II Prostate Cancer AJCC v8
- Stage IIA Prostate Cancer AJCC v8
- Stage IIB Prostate Cancer AJCC v8
- Stage IIC Prostate Cancer AJCC v8

## Interventions

- **RADIATION:** High-Dose Rate Brachytherapy
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT04399824
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-03
- **Primary completion:** 2020-04-03
- **Final completion:** 2020-04-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study did not open
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04399824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04399824, "Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04399824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*